# MicroPort introduces Yunfeng Fund III as partner in CRM business acquisition

MicroPort Medical (Hong Kong) and SRL (owned by Yunfeng Fund III) agreed to jointly fund the acquisition of LivaNova's CRM business for up to $200 million. MicroPort Hong Kong will hold 75% and SRL 25% of the buyer, MicroPort Cardiac Rhythm B.V.

- Type: Acquisition
- Announced: 2018-02-20
- Where: China
- Value: $200.0M
- Status: announced
- Products: cardiac rhythm management (CRM) devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [LivaNova](https://endata.com/companies/8038.md) (target)
- [MicroPort Medical](https://endata.com/companies/30166.md) (acquirer)
- [Yunfeng Fund III](https://endata.com/companies/30167.md) (investor)

## Sources

- [beta.zhitongcaijing.com](http://beta.zhitongcaijing.com/content/detail/107674.html), 2018-02-20: "微创香港及SRL同意向买方出资，以使买方完成收购事项，完成出资后，买方由微创香港以75%及SRL以25%拥有。"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.